Most clinics hire a stem cell therapy marketing agency without a clear picture of what the first three months should look like. So they judge the agency on the only thing they can see, which is lead volume, and they judge it too early. By month two they are either thrilled about cheap leads that never book or ready to fire a firm that was doing the right work in the right order.

A good stem cell marketing agency spends the first 30 days on measurement and the patient conversation, days 31 to 60 on launching channels against a cost target you set together, and days 61 to 90 on cutting what does not produce consultations. If you are not seeing cost per booked consult by day 90, something is wrong.

This piece is about what the work should look like once you have hired someone. For what the engagement covers and how we run it, see our stem cell therapy marketing agency page. For the ongoing job beyond the first quarter, see what a regenerative medicine marketing agency should actually do. If you are still deciding whether to hire at all, start with in-house vs agency clinic marketing, which covers how to evaluate a firm and the red flags to walk away from. If the question is which one, we compare the agencies in this category and say who each is right and wrong for.

What Makes Stem Cell Marketing Different

A general agency can run ads for a dentist or a med spa with a standard playbook. Stem cell and regenerative medicine break that playbook in three places.

The platforms restrict the category. Google and Meta both limit what you can say about stem cell treatments, and claims that would be routine for other services get ads rejected or accounts flagged. An agency has to know where those lines are before it writes a word of copy. Our guide to why stem cell ads get rejected covers the specifics.

The sale is long and expensive. A patient considering a five-figure, mostly cash-pay treatment does not book from one ad. They research, hesitate, ask their spouse, and come back weeks later. Marketing that only measures the first click misses most of what actually happens.

Most of the revenue is decided inside the clinic. How fast a lead gets a call, how the consultation runs, and whether anyone follows up after a "let me think about it" matter more than the ad. An agency that ignores that is optimizing the cheap end of the funnel.

Days 1 to 30: Measure Before You Spend

The first month should feel slower than you expect. That is a good sign.

Tracking that reaches revenue. Every lead should be tied to its source, and every source should be tied to booked consults, shows, and closed cases. If the agency launches ads before this exists, you will spend three months generating numbers nobody can interpret. See conversion tracking for stem cell clinics for what that setup involves.

Your numbers, written down. Average case value, current close rate, show rate, and the most you can afford to pay for a new patient. That last number is the target every later decision gets measured against. The method is in patient acquisition cost for stem cell clinics.

A look at the patient conversation. A serious agency will ask to hear how leads are answered today, how long they wait, and what happens after a consultation ends without a decision. If the first five minutes after an inquiry are broken, more traffic makes the problem more expensive.

Offer and compliance review. What are you actually promoting, which condition, at what entry point, and what can legally be said about it? This is where a specialist earns the premium over a generalist.

By day 30 you should have: working attribution, an agreed cost-per-patient ceiling, a written read on your intake and follow-up, and approved creative ready to launch.

Days 31 to 60: Launch Against a Target

Now the money goes out, but in a controlled way.

Most regenerative clinics do best with Meta creating demand and Google catching patients who are already searching. The reasoning is in Meta ads vs Google ads for clinics. The agency should launch with a small number of offers and audiences, not a dozen at once, so the results tell you something.

Leads should land somewhere that responds immediately, with an automated text and a person calling within minutes during business hours. Follow-up for the ones who do not book should already be running. Clinic follow-up sequences covers what those look like.

By day 60 you should have: real cost per lead and cost per booked consult by channel, and enough volume to see which offers are pulling. You will not have reliable cost per patient yet, because the decision cycle has not finished. Do not let anyone, including yourself, call the program a success or a failure on month-two revenue.

Days 61 to 90: Cut and Concentrate

The third month is about removing things. Audiences that produce leads but not consultations get turned off. Offers that attract the wrong patients get rewritten or dropped. Budget moves toward whatever is producing booked consults under the target.

This is also when the first cases from month-two leads start closing, so you get your first honest look at cost per patient. Treat it as an early read, not a verdict.

By day 90 you should have: cost per booked consult you trust, a first estimate of cost per patient, and a clear list of what is getting more budget and what was shut off and why.

What the Monthly Report Should Show

If the report leads with impressions, reach, and click-through rate, the agency is reporting on what it controls rather than what you are paying for. Those numbers belong in an appendix.

The front page should show leads, booked consults, shows, and closed cases by source, with spend next to each. It should flag where leads are being lost, including inside your clinic, because a good partner tells you when the problem is your phones. The full metric set is in stem cell clinic marketing ROI metrics.

Warning Signs in the First 90 Days

Ads went live in week one. Speed feels like progress, but it usually means nothing is being measured past the lead.

Nobody asked about your close rate. An agency that does not know it cannot know whether a lead source is profitable.

Lead volume is high and consult bookings are flat. Cheap leads are easy to produce in this category. Booked consultations are the number that matters.

Ad accounts are in their name. Your accounts, your pixel, your history. If leaving means starting over, you are renting your own data.

Frequently Asked Questions

How long before a stem cell marketing agency produces patients?

Expect consultations within the first two months of launch and closed cases from around month three, because the decision cycle for a high-ticket treatment runs weeks. Predictable monthly patient volume usually takes longer than that.

Should the agency also handle follow-up and appointment setting?

It can, and for clinics without a dedicated coordinator it often should. What matters is that someone owns it. Leads that wait hours for a call book at a much lower rate than leads called within minutes.

What should a clinic provide in the first month?

Access to ad accounts, the CRM or wherever leads land, your current numbers even if they are rough, and an hour a week from whoever owns the patient conversation. An agency working without those is guessing.

Is a specialist agency worth paying more for?

Usually, in this category. A generalist spends its first months learning the compliance rules and the long sales cycle on your budget. A specialist should arrive knowing both.

Want to see what the first 90 days would look like for your clinic? Book a free strategy call.